title: Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer.
authors.forename: Janakiraman
authors.initials: J
authors.lastname: Subramanian
authors.forename: Vamsidhar
authors.initials: V
authors.lastname: Velcheti
authors.forename: Maria Q
authors.initials: MQ
authors.lastname: Baggstrom
authors.forename: Ramaswamy
authors.initials: R
authors.lastname: Govindan
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016001:Confidence Intervals; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D011336:Probability; D012189:Retrospective Studies; D016879:Salvage Therapy; D016019:Survival Analysis; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D014747:Vinblastine; D000077235:Vinorelbine; D000093542:Gemcitabine